Zoetis' proposed acquisition of Jurox not opposed, subject to divestiture* The ACCC will not oppose the proposed acquisition of Jurox by Zoetis after accepting a court-enforceable undertaking from Zoetis to divest Jurox’s intramammary product range, consisting of intramammary antibiotics for dry and lactating cows and teat sealants for cows. Zoetis and Jurox develop, manufacture and sell animal health products. They are two of the leading suppliers in Australia of teat sealants and intramammary antibiotics for lactating and dry cows, which are products used to treat or prevent bacterial
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.